EMERGENT BIOSOLUTIONS INC. Stockholders' Equity Note, Spinoff Transaction
EMERGENT BIOSOLUTIONS INC. (EBS) reported Stockholders' Equity Note, Spinoff Transaction of -$148.40 million for the 12-month period ending 2016-12-31, per its 10-K filed 2019-02-22.
Discontinued › Shareholders' Equity
us-gaap:StockholdersEquityNoteSpinoffTransaction · last filed 2019-02-22
- EMERGENT BIOSOLUTIONS INC. stockholders' equity note, spinoff transaction for fiscal 2016 was -$148.40M.
| Period end | Stockholders' Equity Note, Spinoff Transaction 12 month | Stockholders' Equity Note, Spinoff Transaction 12 month as first filed |
|---|---|---|
| 2016-12-31 | -$148.40M 10-K · filed 2019-02-22 | -$148.44M 10-K · filed 2017-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |